Cargando…
Dosing (225)Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity
PURPOSE: The aim of this retrospective analysis is to estimate the most appropriate single cycle and cumulative doses of (225)Ac-DOTATOC in patients treated for somatostatin-receptor-expressing cancers. METHODS: (225)Ac-DOTATOC was administered to thirty-nine patients with various somatostatin-recep...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712294/ https://www.ncbi.nlm.nih.gov/pubmed/34448031 http://dx.doi.org/10.1007/s00259-021-05474-1 |